Eva Morava, MD
Dr Morava did her specialty trainings in Europe and also in the US, as pediatrician, geneticist and metabolic specialist. Her major clinical expertise is inborn errors of metabolism. She has decades of experience in the diagnostics, follow-up and treatment in IEM, especially in mitochondrial disorders and congenital disorders of glycosylation.
Dr Morava is actively involved in developing novel therapies in genetic disorders. She is involved in clinical trials. Currently she focusses on clinical trials in congenital disorders of glycosylation (CDG). She is also the main PI of the multicenter study on the Natural history of congenital disorders of glycosylation.
Dr Morava is the Editor in Chief of the Journal of Inherited Metabolic Disease. This journal has the mission to publish on the most current topics, clinical findings and research in inborn errors of metabolism, and share the knowledge with colleagues and scientists.
Dr Morava has a research laboratory, focusing on translational research in mitochondrial disorders and congenital disorders of glycosylation. She is working in close collaboration with the UMDF and CDG-CARE, where she is also an advisory board member.
Dr Morava is passionate about education, especially patient education. She is regularly involved in patient educational events and she aims at sharing difficult genetic material with her patients as a partner.